About Us
AI is rapidly changing the biosecurity landscape. Azimuth Labs researches emerging risks from AI-enabled threats, and how to defend against malicious actors.
We focus on understanding how frontier AI capabilities may lower barriers for non-state actors to develop chemical and biological threats—and how to build defenses before these risks materialize.
We're in early formation. More details coming soon.
Matthew Rubashkin
Founder
Matthew Rubashkin founded Azimuth Labs to address emerging biosecurity risks from frontier AI systems. He holds a PhD in Bioengineering from UC Berkeley/UCSF and has spent his career at the intersection of AI and the biosciences—including developing AI-based safety systems, with work published in Nature and Science.
Matthew has conducted red-teaming evaluations for foundation model labs and previously led engineering teams building crisis detection AI systems. He also runs Zaro Data, an AI engineering consultancy.
Connect on LinkedIn →